513 related articles for article (PubMed ID: 30171729)
41. miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2.
Dong Y; Gao Y; Xie T; Liu H; Zhan X; Xu Y
Biomed Res Int; 2021; 2021():9950749. PubMed ID: 34307682
[TBL] [Abstract][Full Text] [Related]
42. MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1.
Maolakuerban N; Azhati B; Tusong H; Abula A; Yasheng A; Xireyazidan A
Cancer Biol Ther; 2018 Apr; 19(4):282-291. PubMed ID: 29394133
[TBL] [Abstract][Full Text] [Related]
43. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
[No Abstract] [Full Text] [Related]
44. LncRNA SNHG17 promotes tumor progression and predicts poor survival in human renal cell carcinoma via sponging miR-328-3p.
Wu J; Dong G; Liu T; Zhang S; Sun L; Liang W
Aging (Albany NY); 2021 Sep; 13(17):21232-21250. PubMed ID: 34497156
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-590-5p regulates cell viability, apoptosis, migration and invasion of renal cell carcinoma cell lines through targeting ARHGAP24.
Wang L; Wei WQ; Wu ZY; Wang GC
Mol Biosyst; 2017 Nov; 13(12):2564-2573. PubMed ID: 29019371
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.
Zaman MS; Thamminana S; Shahryari V; Chiyomaru T; Deng G; Saini S; Majid S; Fukuhara S; Chang I; Arora S; Hirata H; Ueno K; Singh K; Tanaka Y; Dahiya R
PLoS One; 2012; 7(11):e50203. PubMed ID: 23189187
[TBL] [Abstract][Full Text] [Related]
47. MiR-200a-3p promotes gastric cancer progression by targeting DLC-1.
Li Z; Wang Y; Liu S; Li W; Wang Z; Jia Z; Zhu Z; Bao Y
J Mol Histol; 2022 Feb; 53(1):39-49. PubMed ID: 34751841
[TBL] [Abstract][Full Text] [Related]
48. MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.
Li JL; Luo P
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):97-108. PubMed ID: 31957822
[TBL] [Abstract][Full Text] [Related]
49. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
Zhai Q; Zhou L; Zhao C; Wan J; Yu Z; Guo X; Qin J; Chen J; Lu R
Biochem Biophys Res Commun; 2012 Mar; 419(4):621-6. PubMed ID: 22369946
[TBL] [Abstract][Full Text] [Related]
50. miR-362-3p targets nemo-like kinase and functions as a tumor suppressor in renal cancer cells.
Zou X; Zhong J; Li J; Su Z; Chen Y; Deng W; Li Y; Lu S; Lin Y; Luo L; Li Z; Cai Z; Tang A
Mol Med Rep; 2016 Jan; 13(1):994-1002. PubMed ID: 26647877
[TBL] [Abstract][Full Text] [Related]
51. A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma.
Yu R; Yao J; Ren Y
J Cell Mol Med; 2020 Sep; 24(17):10177-10188. PubMed ID: 32729669
[TBL] [Abstract][Full Text] [Related]
52. LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expression.
Cai X; Zhang X; Mo L; Zhu J; Yu H
Cancer Biomark; 2020; 27(4):493-504. PubMed ID: 31958075
[TBL] [Abstract][Full Text] [Related]
53. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
[TBL] [Abstract][Full Text] [Related]
54. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.
Xu X; Wu J; Li S; Hu Z; Xu X; Zhu Y; Liang Z; Wang X; Lin Y; Mao Y; Chen H; Luo J; Liu B; Zheng X; Xie L
Mol Cancer; 2014 May; 13():109. PubMed ID: 24886554
[TBL] [Abstract][Full Text] [Related]
55. microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2).
Gu DH; Mao JH; Pan XD; Zhu H; Chen X; Zheng B; Shan Y
Oncotarget; 2017 Apr; 8(16):26334-26343. PubMed ID: 28412750
[TBL] [Abstract][Full Text] [Related]
56. miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.
Jiang K; Sun F; Zhu J; Luo G; Ban Y; Zhang P
Mol Genet Genomic Med; 2019 Aug; 7(8):e833. PubMed ID: 31250570
[TBL] [Abstract][Full Text] [Related]
57. Circ_0039569 Competes with MARCKS for miR-133b Binding Sites to Promote the Progression of Renal Cell Carcinoma.
Zhao P; Zhang J
Nephron; 2022; 146(4):404-417. PubMed ID: 35086110
[TBL] [Abstract][Full Text] [Related]
58. The E2F1-miR-520/372/373-SPOP Axis Modulates Progression of Renal Carcinoma.
Ding M; Lu X; Wang C; Zhao Q; Ge J; Xia Q; Wang J; Zen K; Zhang CY; Zhang C
Cancer Res; 2018 Dec; 78(24):6771-6784. PubMed ID: 30348808
[TBL] [Abstract][Full Text] [Related]
59. miR-200a-3p plays tumor suppressor roles in gastric cancer cells by targeting KLF12.
Jia C; Zhang Y; Xie Y; Ren Y; Zhang H; Zhou Y; Gao N; Ding S; Han S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3697-3703. PubMed ID: 31500453
[No Abstract] [Full Text] [Related]
60. MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.
Dasgupta P; Kulkarni P; Majid S; Shahryari V; Hashimoto Y; Bhat NS; Shiina M; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
Mol Cancer Ther; 2018 May; 17(5):1061-1069. PubMed ID: 29440295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
